Have You Noticed That Democrats Aren't Celebrating America's Recent Victories?
Trump Slapped the Press Around During the Easter Egg Roll
How Iran's Military Responded to Trump's Threat
CNN Analyst Delivers Brutal Wake-Up Call to Democrats
Inside the Last-Ditch Effort to Reach Ceasefire Agreement Before Trump Unleashes Hell on...
President Trump Held a Major Press Conference Today. Here's What He Said.
Artemis Crew Received a Special Message Today
There's Some Shady Stuff Happening With Mail-In Ballots in Green Bay, Wisconsin
Iran's Greatest Ally Is the Left
Gun Control Group Blasts Film For Not Being Anti-Gun Enough
Here Is What Iran Was Able to Salvage From US Equipment Left Behind...
President Trump Endorses Steve Hilton for CA Governor
Inside the High-Stakes Mission That Saved an F-15E Officer From Enemy Territory
U.S. and Iran Receive 45-Day Ceasefire Proposal As Pressure Mounts to Open the...
No King but Christ
Tipsheet

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order
AP Photo/Evan Vucci

President Trump signed an executive order on Monday ending current and future federal funding for gain-of-function research in certain countries, such as China and Iran.

Advertisement

The order seeks to protect Americans from this type of “dangerous” research and any lab accidents and biosecurity incidents that most likely caused the COVID-19 pandemic.

American innovation will not be impeded by the order, according to the White House, but it will increase the safety and security of biological research in the U.S.

  • For decades, policies overseeing gain-of-function research on pathogens, toxins, and potential pathogens have lacked adequate enforcement, transparency, and top-down oversight. Researchers have not acknowledged the legitimate potential for societal harms that this kind of research poses.
  • The Biden Administration allowed dangerous gain-of-function research with insufficient levels of oversight and actively approved Federal life-science research funding in China and other countries.
  • The 2024 United States Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential (“DURC/PEPP”) and the 2024 Framework for Nucleic Acid Synthesis Screening are the latest examples of inadequate policies that rely on self-reporting and fail to protect Americans from dangerous research practices.
  • This Order pauses research using infectious pathogens and toxins in the United States that may pose a danger to American citizens until a safer, more enforceable, and transparent policy governing such research can be developed and implemented. It directs the Director of the Office of Science and Technology Policy (OSTP) and the National Security Advisor (NSA) to work with funding agencies to develop such a policy within 120 days.
  • Unlike previous policies, this Order contains enforcement and reporting mechanisms that will strengthen oversight and discourage subjective interpretation of policies that researchers have used in the past to evade biosafety and biosecurity oversight. (White House)
Advertisement

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement